Piperonyl Butoxide Tied to Mental Development Delay

Article

Prenatal exposure to piperonyl butoxide may delay mental development at 36 months of age, according to research published online Feb. 7 in Pediatrics.

THURSDAY, Feb. 10 (HealthDay News) -- Prenatal exposure to piperonyl butoxide may delay mental development at 36 months of age, according to research published online Feb. 7 in Pediatrics.

Megan K. Horton, Ph.D., of Columbia University in New York City, and colleagues performed a prospective study on the effect of prenatal exposure to two residential pesticides: permethrin and piperonyl butoxide. They tested a group of non-smoking black and Dominican mothers and newborns living in low-income neighborhoods in New York City. Ambient air levels were measured with air monitors in the mothers homes to obtain prenatal permethrin and piperonyl butoxide levels. Permethrin was also measured in maternal and umbilical cord plasma collected on delivery.

According to the researchers, the 36-month-olds with high prenatal exposure to piperonyl butoxide (more than 4.34 ng of piperonyl butoxide per cubic meter) showed greater delays in cognitive development, scoring a mean of 3.9 points lower on the Bayley Mental Development Index, compared to those with lower exposure. However, prenatal exposure to permethrin appeared to have no effect on mental or motor development at 36 months of age.

"These findings should be considered preliminary and may be useful for generating future hypotheses," the authors write.

Related Content

Antenatal HIV Exposure Tied to Lower Infant Antibodies
 

Recent Videos
Efficacy found from biopsychosocial approach to women’s sexual health | Image Credit: hermd.com.
Dr. Somi Javaid highlights disparities in sexual health | Image Credit: hermd.com.
How advancements in IVF are impacting embryologist workload and patient care | Image Credit: fertility.coopersurgical.com/our_experts
Study finds no causal link between maternal health in pregnancy and autism risk | Image Credit: med.nyu.edu/faculty.
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
How the cobas liat assay panels improve STI detection | Image Credit: labqualityconfab.
Screening-to-diagnosis interval vital for gestational diabetes outcomes | Image Credit: ultracon2024.eventscribe.net
Related Content
© 2025 MJH Life Sciences

All rights reserved.